Related Experiment Video
Updated: May 31, 2026
09:57
Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
Ultra-high-sensitivity next-generation sequencing-based MRD predicts outcome in intensively treated older patients
Augustin Boudry1,2, Laurène Fenwarth1,2, Raphaël Itzykson3,4,5
1Laboratory of Hematology, Biology and Pathology Center, CHU Lille, Lille, France.
Blood Cancer Journal
|May 28, 2026
Abstract
No abstract available in PubMed .
